BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34061356)

  • 1. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    Konishi T; Yoshidome H; Shida T; Furukawa K; Takayashiki T; Kuboki S; Takano S; Miyazaki M; Ohtsuka M
    J Surg Oncol; 2021 Sep; 124(4):598-606. PubMed ID: 34061356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.
    Bredt LC; Rachid AF
    World J Surg Oncol; 2014 Dec; 12():391. PubMed ID: 25528650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
    Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
    World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
    Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
    Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
    Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases.
    Imai K; Yamashita YI; Miyamoto Y; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Baba H
    Int J Clin Oncol; 2018 Oct; 23(5):908-916. PubMed ID: 29619592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcome after repeat resection for colorectal liver metastases.
    Saiura A; Yamamoto J; Koga R; Takahashi Y; Takahashi M; Inoue Y; Ono Y; Kokudo N
    Ann Surg Oncol; 2014 Dec; 21(13):4293-9. PubMed ID: 24962942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.
    Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M
    J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.
    Ardito F; Arena V; Vellone M; Grande G; Pennacchia I; Majellaro F; Giovannini I; Vecchio FM; Nuzzo G; Giuliante F
    J Gastrointest Surg; 2014 Nov; 18(11):1987-93. PubMed ID: 25231080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver metastases from colorectal cancer: present surgical approach.
    Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
    Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of poor performance status after resection of colorectal liver metastases.
    Strandberg Holka P; Eriksson S; Eberhard J; Bergenfeldt M; Lindell G; Sturesson C
    World J Surg Oncol; 2018 Jan; 16(1):3. PubMed ID: 29304822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.